entity

pathological_tau

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about pathological_tau: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections

2Hypotheses

3Analyses

1Outgoing

4Incoming

0Experiments

5Debates

No AI portrait yet

Outgoing (1)

Target	Relation	Type	Str
neurodegeneration	causes	disease	0.90

Incoming (4)

Source	Relation	Type	Str
post_translational_modifications	contributes_to	pathway	0.90
post_translational_modifications	causes	process	0.70
nanobody	targets	therapeutic_agent	0.70
glycan_pattern	biomarker_for	biomarker	0.50

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Selective p38γ MAPK Inhibition Reduces Pathological Tau Phos	0.625	neurodegeneration	Test
O-GlcNAcylation at T212 competes with phosphorylation to red	0.380	alzheimers-disease-and-related-tauopathies	How can ESCRT or SNARE targeting achieve

Mentioning Analyses (3)

Scientific analyses that reference this entity

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

molecular biology | 2026-04-09 | 7 hypotheses Top: 0.455

Which specific post-translational modifications on pathological tau create drugg

neurodegeneration | 2026-04-09 | 3 hypotheses Top: 0.455

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

neurodegeneration | 2026-04-09 | 7 hypotheses Top: 0.455

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (5)

Multi-agent debates referencing this entity

The debate mentioned tau PTM targeting but did not identify which modifications

closed · Rounds: 4 · Score: 0.84 · 2026-04-12

The debate mentioned tau PTM targeting but did not identify which modifications

closed · Rounds: 4 · Score: 0.71 · 2026-04-12

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Which specific post-translational modifications on pathological tau create drugg

closed · Rounds: 4 · Score: 0.50 · 2026-04-10

Can nanobodies achieve selective membrane penetration into tau-containing vesicl

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Related Research

Hypotheses and analyses mentioning pathological_tau in their description or question text

No additional research found